Clínic Barcelona

Research provides new clues about iron toxicity in Parkinson's disease and explains the paradoxical effect of deferiprone

The results contrast with those of 4 previous independent clinical trials and could provide relevant information on the role of iron accumulation in the process of neurodegeneration.

Yaroslau Compta, national coordinator of the study and researcher of the IDIBAPS group Parkinson's disease and other neurodegenerative movement disorders: clinical and experimental research.

Related contents
Keep reading about:

Related news